Chao Qiu

10PUBLICATIONS

21CO-AUTHORS

Biologically active moleculesPharmacogenomicsStructure and dynamics of materialsBiofabricationMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 26, 2026

Correction: Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir.

|Jun 27, 2025

Safety, Tolerability, and Immunogenicity of a DNA Vaccine (pGX9501) Against SARS-CoV-2 in Healthy Volunteers: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, and Dose-Ranging Phase I Trial.

Haijing Yang, Yang Zhou, Xin Cheng

|Apr 10, 2025

Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir.

Yifan Zhang, Yanmin Wan, Cuiyuan Guo

|Jun 17, 2024

The Critical Role of the Shroom Family Proteins in Morphogenesis, Organogenesis and Disease.

Wanling Liu, Lei Xiu, Mingzhe Zhou

|Feb 28, 2024

BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion.

Xueping Yu, Feifei Yang, Zhongliang Shen

|Dec 15, 2023

Correction for Lin et al., "Clinical Diagnostic Performance of Droplet Digital PCR for Suspected Bloodstream Infections".

Ke Lin, Yuanhan Zhao, Bin Xu

Pageof 2

Frequent Collaborators

Yanmin Wan

Haocheng Zhang

Youchun Wang

Yang Li

Tao Xu

Yang Zhou

Ke Lin

Xueping Yu

Bin Wang

Richeng Mao

Frequent Collaborators

Yanmin Wan

Haocheng Zhang

Youchun Wang

Yang Li